After hitting a regulatory roadblock in 2022, Sanofi’s consumer healthcare business Opella has secured the FDA’s blessing to ...

Gov. Gavin Newsom’s ambitious plan to produce a cheap, generic insulin for the 3.2 million Californians with diabetes is behind the schedule he announced ...

You'll get access to an ad-free website with a faster photo browser, the chance to claim free tickets to a host of events ...

In 2024, drug makers lowered the cost of dozens of common medications to avoid penalties imposed by the American Rescue Plan, Katie Thomas of ...

The lawsuit said an “unfair and deceptive conspiracy” by drug makers and drug distributors fixed prices for Georgians.

Cobb County has filed a lawsuit accusing several major insulin manufacturers and pharmacy benefit managers (PBMs) of ...

Columbus City Attorney Zach Klein announced that the city has filed a lawsuit against several drug companies and pharmacy ...

While this option may be less expensive and seems convenient, it’s best to consult a doctor about dosage if you use it, says Joshua J. Neumiller, CDCES, PharmD, the president elect of ...

The nationally recognized law firm Baron & Budd is pleased to announce that six of the firm's shareholders have been selected to the 2025 edition of the Lawdragon 500 Leading Lawyers in America.

Braman Motors' lawyers believe their client is the first ERISA plan sponsor to join a big group of plaintiffs with cases ...

The global smart insulin pens market, currently estimated at US$ 3,927.3 million in 2023, is projected to exhibit robust ...

A Flori­da-based car deal­er has joined mount­ing lit­i­ga­tion against Eli Lil­ly, No­vo Nordisk and Sanofi over what it calls the “ex­or­bi­tant” price of in­sulin. … ...